Rchr
J-GLOBAL ID：200901054472799925   Update date: Apr. 14, 2024

Yosida Kazuhiro

ヨシダ カズヒロ | Yosida Kazuhiro
Affiliation and department：
Gifu University Graduate School of Medicine

About Gifu University Graduate School of Medicine


Other affiliations (3)：
  • 研究推進・社会連携機構生命の鎖統合研究センター活かす領域  教授(兼)(大学院医学系研究科)
  • 医学系研究科  教授
  • 医学部附属病院  部長・センター長等(医学部附属病院)
Research field  (4)： Respiratory surgery ,  Cardiovascular surgery ,  General surgery, pediatric surgery ,  Digestive surgery
Research keywords  (29)： 抗がん剤 ,  バイオケミカルモジュレイション ,  効果予測システム ,  Paclitaxel ,  Verapamil ,  CPT-11 ,  消火器がん ,  トポイソメラーゼI ,  トポイソメラーゼII ,  5FU ,  臨床研究 ,  P-glycoprotein ,  アポプトーシス ,  アドリアマイシン ,  トポイソメレースII ,  FANCJ ,  マイクロアレイ ,  Oxaliplatin ,  OPRT ,  消化器がん ,  テイラード医療 ,  バイオインフォマティクス ,  synergistic effect ,  トポイソメレースI ,  耐性 ,  遺伝子発現解析 ,  cDNA differential display ,  転移関連遺伝子 ,  癌転移
Research theme for competitive and other funds  (25)：
  • 2015 - 2020 RAS野生型進行大腸癌患者におけるFOLFOXIRI+セツキシマブとFOLFOXIRI+ベバシズマブの最大腫瘍縮小率(DpR)を検討する無作為化第II相臨床試験(JACCROCC-13)
  • 2017 - 2020 New classification of gastric cancer based on genome analysis for precision medicine
  • 2016 - 2020 RAS遺伝子(KRAS/NRAS遺伝子)野生型で化学療法未治療の切除不能進行再発大腸癌患者に対するmFOLFOX6+ベバシズマブ併用療法とmFOLFOX6+パニツムマブ併用療法の有効性及び安全性を比較する第III相無作為化比較試験(PARADIGMstudy)
  • 2015 - 2020 JBCRG-M05「HER2陽性の進行・再発乳癌に対するペルツズマブ再投与の有用性を検証する第III相臨床研究-ペルツズマブ再投与試験-」
  • 2016 - 2020 内分泌療法耐性エストロゲン受容体陽性転移乳がんに対する二次内分泌療法のコホート研究(HORSE-BC研究)
Show all
Papers (330)：
  • Yasuhiro Kodera, Kazuhiro Yoshida, Mitsugu Kochi, Takeshi Sano, Wataru Ichikawa, Yoshihiro Kakeji, Yu Sunakawa, Masahiro Takeuchi, Masashi Fujii. Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2023
  • Yuta Sato, Manabu Futamura, Yoshihiro Tanaka, Hiroshi Tsuchiya, Masahiro Fukada, Toshiya Higashi, Itaru Yasufuku, Ryuichi Asai, Jesse Yu Tajima, Shigeru Kiyama, et al. Clinical Possibility of Caenorhabditis elegans as a Novel Evaluation Tool for Esophageal Cancer Patients Receiving Chemotherapy: A Prospective Study. Cancers. 2023. 15. 15
  • Hirokatsu Hayashi, Akitaka Makiyama, Naoki Okumura, Itaru Yasufuku, Chiemi Saigo, Tamotsu Takeuchi, Tatsuhiko Miyazaki, Yoshihiro Tanaka, Nobuhisa Matsuhashi, Katsutoshi Murase, et al. Gastric carcinosarcoma with FGFR2 amplification under long-term control with pazopanib: a case report and literature review. BMC Gastroenterology. 2022. 22. 1
  • Hiromichi Maeda, Hideki Endo, Hiroyuki Yamamoto, Hiroaki Miyata, Masaya Munekage, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Kazuhiro Yoshida, Hiroki Yamaue, et al. Effects of the COVID-19 pandemic on gastroenterological surgeries in 2020: A study using the National Clinical Database of Japan. Annals of Gastroenterological Surgery. 2022. 7. 3. 407-418
  • MASAHIRO FUKADA, KATSUTOSHI MURASE, TOSHIYA HIGASHI, RYOMA YOKOI, YOSHIHIRO TANAKA, NAOKI OKUMURA, NOBUHISA MATSUHASHI, TAKAO TAKAHASHI, KAZUHIRO YOSHIDA. Early Predictive Factors for Postoperative Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Cancer. Cancer Diagnosis & Prognosis. 2022. 2. 4. 452-461
ｍore...
MISC (346)：
  • Hideharu Tanaka, Hisashi Imai, Toshiya Higashi, Katsutoshi Murase, Natsuko Suzui, Yoshihiro Tanaka, Naoki Okumura, Nobuhisa Matsuhashi, Takao Takahashi, Kazuhiro Yoshida. Borderline Resectable Pancreatic Cancer Treated By Pancreaticoduodenectomy With Splenic Artery Resection (PD-SAR) After Neoadjuvant Chemotherapy: A Case Report. PANCREAS. 2022. 51. 6. 709-709
  • 田中秀治, 今井寿, 東敏弥, 村瀬勝俊, 酒々井夏子, 田中善宏, 奥村直樹, 松橋延壽, 高橋孝夫, 吉田和弘. Borderline resectable pancreatic cancer treated by pancreaticoduodenectomy with splenic artery resection (PD-SAR) after neoadjuvant chemotherapy: a case report. 膵臓(Web). 2021. 36. 2
  • 田中秀治, 村瀬勝俊, 波多野裕一郎, 松橋延壽, 高橋孝夫, 吉田和弘. A Case of Jejunal Dieulafoy’s Lesion with Hemorrhagic Shock, in Which Preoperative Double-Balloon Endoscopy and Intraoperative Endoscopy Allowed Avoidance of Massive Intestinal Resection. 日本腹部救急医学会雑誌. 2021. 41. 5
  • 佐藤悠太, 田中善宏, 今井健晴, 小塩英典, 間瀬純一, 畑中勇治, 末次智成, 藤井宏典, 奥村直樹, 松橋延壽, et al. Biweekly-DCF術前補助化学療法を受けた食道癌患者の骨格筋量がもたらす影響. 外科と代謝・栄養. 2021. 55. 4
  • 松本 圭太, 松橋 延壽, 高橋 孝夫, 末次 智成, 今井 健晴, 棚橋 利行, 松井 聡, 今井 寿, 田中 善宏, 山口 和也, et al. T1a直腸癌に対して根治的EMR施行後、局所再発した1例. 日本癌治療学会学術集会抄録集. 2019. 57回. P22-5
ｍore...
Books (2)：
  • Prediction of peritoneal recurrence by intra peritoneal CEA protein and mRNA in gastric carcinomas
    4th International Gastric Cancer Congress 2001
  • TS-1, a new oral tegafur compound, is active for peritoneal disseminated disease in gastric carcinomas
    4th International Gastric Cancer Congress Monduzzi Editore 2001
Education (4)：
  • - 1990 Hiroshima University Graduate School, Division of Medical Sciences
  • - 1990 Hiroshima University
  • 1978 - 1984 Hiroshima University Faculty of Medicine School of Medicine
  • - 1984 Hiroshima University Faculty of Medicine
Professional career (1)：
  • 医学博士 (広島大学)
Work history (4)：
  • 2022/04 - 現在 Gifu University President
  • 2018/04 - 2022/03 Gifu University Hospital Director of Gifu University Hospital
  • 2007/08 - 2022/03 Gifu University
  • 2002/06 - 2007/07 Former Institution / Organization Hiroshima University Hospital Assistant Professor
Awards (7)：
  • 2020 - Japanese Society of Gastroenterological Surgery Best article award 2020
  • 2017 - Gifu University Senior Professor
  • 2013 - American Society of Clinical Oncology (ASCO) Best of ASCO
  • 2012 - European Society for Medical Oncology (ESMO) Best of ESMO
  • 1998 - 日本外科系連合学会賞
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM